Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Astrazeneca PLC Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $4.37 Billion
- Q2 2025
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 7,016 shares of AZN stock, worth $588,151. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,016
Previous 3,845
82.47%
Holding current value
$588,151
Previous $282,000
73.76%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
498MCall Options Held
7.11MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.35 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.45 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.63 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.61 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $260B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...